Natera, Inc. , a global leader in cell-free DNA and precision medicine, and Aveta Biomics, Inc., a clinical-stage immuno-oncology company advancing first-in-class oral immunotherapies for solid tumors ...
South Korean researchers have developed an automated, modular cell-free protein synthesis platform that slashes preparation ...
DNA from an unknown male was found under Maggie Murdaugh's nails, and Alex Murdaugh's lawyers want to test it to find out ...
Alex Murdaugh got a new court date for his murder retrial, and the public learned a little more about the judge who will be ...
A handful of start-up firms are testing therapies that target specific epigenetic markers to treat everything from high ...
IntelliGenome, Inc., a molecular diagnostics company advancing next-generation tuberculosis detection technologies, today announced that Colombia's National Institute for Food and Drug Surveillance ...
The mechanical process of cell division exerts powerful, if microscopic, forces. How do the molecular machines that power it ...
Commercialized PGT risks not only flattening human variation but swelling the moral burdens of parenthood and further eroding ...
The Alex Murdaugh murder case has already been called South Carolina's trial of the century. Now we know when it'll start ...
The Chosun Ilbo on MSN
GC Genome advances AI multi-cancer early screening
GC Genome, which entered the KOSDAQ market in June of last year, is accelerating its leap toward becoming a global precision medicine company as it marks its first anniversary since listing. Building ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results